Exact Mass: 337.88700719999997

Exact Mass Matches: 337.88700719999997

Found 15 metabolites which its exact mass value is equals to given mass value 337.88700719999997, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Proxigermanium

Bis (2-Carboxyethylgermanium)sesquioxide

C6H10Ge2O7 (337.88681099999997)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist D007155 - Immunologic Factors > D007369 - Interferon Inducers D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Tetrasul sulfoxide

1,2,4-Trichloro-5-(4-chlorobenzenesulphinyl)benzene

C12H6Cl4OS (337.88934660000007)


   
   
   

(3,5-Dibromo-2-hydroxy-4-methoxyphenyl)acetic acid

(3,5-Dibromo-2-hydroxy-4-methoxyphenyl)acetic acid

C9H8Br2O4 (337.8789288)


   
   

2,6-dibromo-4-hydroxy-4-methoxycarbonylmethylcyclohexa-2,5-dien-1-one|4-<(ethoxycarbonyl)methyl>-2,6-dibromo-4-hydroxycyclohexadienone

2,6-dibromo-4-hydroxy-4-methoxycarbonylmethylcyclohexa-2,5-dien-1-one|4-<(ethoxycarbonyl)methyl>-2,6-dibromo-4-hydroxycyclohexadienone

C9H8Br2O4 (337.8789288)


   
   
   
   

methyl 3,5-dibromo-2,4-dihydroxy-6-methylbenzoate

methyl 3,5-dibromo-2,4-dihydroxy-6-methylbenzoate

C9H8Br2O4 (337.8789288)


   
   

Propagermanium

Bis (2-Carboxyethylgermanium)sesquioxide

C6H10Ge2O7 (337.88681099999997)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist D007155 - Immunologic Factors > D007369 - Interferon Inducers D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

samarium nitrate

samarium nitrate

N3O9Sm (337.883198)


   

Tetrasul sulfoxide

Tetrasul sulfoxide

C12H6Cl4OS (337.88934660000007)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS